title: Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma.
authors: Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
authors: W
authors: W
authors: Piao
authors: Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
authors: D
authors: 0000-0003-1205-4156
authors: D
authors: Chau
authors: Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
authors: L M
authors: LM
authors: Yue
authors: Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
authors: Y-L
authors: YL
authors: Kwong
authors: Division of Haematology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
authors: E
authors: E
authors: Tse
mesh_terms: D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000473:pathology*; D010087:Oxides / Q000494:pharmacology / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000187:drug effects* / Q000378:metabolism
chemical_list: D001152:Arsenicals; D010087:Oxides; C107023:p80(NPM-ALK) protein; D011505:Protein-Tyrosine Kinases; D000077237:Arsenic Trioxide